Charles F. Wagner Jr.

CIK: 0001223348

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (17.9%)

Position reduction

Option Exercises (M)1 (3.6%)

Derivative conversions

Awards (A)14 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)8 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TJX

TJX COMPANIES INC /DE/

Director

VRTX

VERTEX PHARMACEUTICALS INC / MA

Officer

Discretionary Trading P&L

Holdings

Transaction History (28 total)

TJX
TJX COMPANIES INC /DE/
Jun 9, 2026
Award(A)
Deferred Stock Units
Direct
637 shares-
TJX
TJX COMPANIES INC /DE/
Jun 9, 2026
Award(A)
Deferred Stock Units
Direct
27 shares-
TJX
TJX COMPANIES INC /DE/
Jun 9, 2026
Award(A)
Deferred Stock Units
Direct
27 shares-
TJX
TJX COMPANIES INC /DE/
Jun 9, 2026
Award(A)
Deferred Stock Units
Direct
637 shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 24, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $485.11$846K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 17, 2026
Tax Payment(F)
Direct
2.3K shares at avg. $483.75$1.1M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 17, 2026
Award(A)
Direct
7.4K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 13, 2026
Tax Payment(F)
Direct
4.6K shares at avg. $487.76$2.2M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 10, 2026
Tax Payment(F)
Direct
3K shares at avg. $468.41$1.4M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 22, 2026
Award(A)
Direct
4.2K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 22, 2026
Award(A)
Direct
9.4K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 6, 2026
Exercise(M)
Direct
9.5K shares at avg. $189.38$1.8M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 6, 2026
Sale(S)
Direct
9.5K shares at avg. $461.00$4.4M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Dec 3, 2025
Sale(S)
Direct
7K shares at avg. $461.00$3.2M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Dec 3, 2025
Sale(S)
Direct
7K shares at avg. $451.00$3.2M
TJX
TJX COMPANIES INC /DE/
Jun 10, 2025
Award(A)
Deferred Stock Units
Direct
21 shares-
TJX
TJX COMPANIES INC /DE/
Jun 10, 2025
Award(A)
Deferred Stock Units
Direct
793 shares-
TJX
TJX COMPANIES INC /DE/
Jun 10, 2025
Award(A)
Deferred Stock Units
Direct
21 shares-
TJX
TJX COMPANIES INC /DE/
Jun 10, 2025
Award(A)
Deferred Stock Units
Direct
793 shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Mar 10, 2025
Sale(S)
Direct
3.3K shares at avg. $500.00$1.6M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 26, 2025
Tax Payment(F)
Direct
5K shares at avg. $479.61$2.4M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 24, 2025
Tax Payment(F)
Direct
3.3K shares at avg. $483.28$1.6M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 14, 2025
Tax Payment(F)
Direct
2.3K shares at avg. $463.46$1.1M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 12, 2025
Award(A)
Direct
6.7K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 10, 2025
Tax Payment(F)
Direct
2.6K shares at avg. $467.98$1.2M

		Type	Shares	Price		Ownership
Jun 9, 2026	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	637	-	-	Direct
Jun 9, 2026	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	27	-	-	Direct
Jun 9, 2026	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	27	-	-	Direct
Jun 9, 2026	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	637	-	-	Direct
Feb 24, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	1,744	$485.11	$846,032	Direct
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,294	$483.75	$1,109,723	Direct
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	7,365	-	$0	Direct
Feb 13, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	4,565	$487.76	$2,226,624	Direct
Feb 10, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	3,045	$468.41	$1,426,308	Direct
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	4,160	-	$0	Direct
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	9,440	-	$0	Direct
Jan 6, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Exercise(M)	9,532	$189.38	$1,805,170	Direct
Jan 6, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	9,532	$461.00	$4,394,252	Direct
Dec 3, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	7,000	$461.00	$3,227,000	Direct
Dec 3, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	7,000	$451.00	$3,157,000	Direct
Jun 10, 2025	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	21	-	-	Direct
Jun 10, 2025	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	793	-	-	Direct
Jun 10, 2025	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	21	-	-	Direct
Jun 10, 2025	TJX TJX COMPANIES INC /DE/	Award(A) Deferred Stock Units	793	-	-	Direct
Mar 10, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	3,298	$500.00	$1,649,000	Direct
Feb 26, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	4,962	$479.61	$2,379,825	Direct
Feb 24, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	3,310	$483.28	$1,599,657	Direct
Feb 14, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,293	$463.46	$1,062,714	Direct
Feb 12, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	6,655	-	-	Direct
Feb 10, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,649	$467.98	$1,239,679	Direct

1-25 of 28 transactions

About WAGNER CHARLES F JR

WAGNER CHARLES F JR (SEC CIK 0001223348) files insider reports with the SEC as Director of TJX COMPANIES INC /DE/ (TJX) and EVP, CO & FO of VERTEX PHARMACEUTICALS INC / MA (VRTX).

Signal8 holds 17 ownership filings by WAGNER CHARLES F JR, all Form 4s, filed between Nov 13, 2024 and Jun 11, 2026. Those filings report 28 transactions, from Nov 11, 2024 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WAGNER CHARLES F JR's filings is in FRAMINGHAM, MA.

Recent filings by WAGNER CHARLES F JR

Jun 9, 2026: Grants or awards of TJX derivative securities (4 lines, Form 4, code A).
Feb 24, 2026: Tax withholding of VRTX shares (Form 4, code F).
Feb 17, 2026: Tax withholding of VRTX shares (Form 4, code F).
Feb 17, 2026: Grant or award of VRTX shares (Form 4, code A).
Feb 13, 2026: Tax withholding of VRTX shares (Form 4, code F).

Other insiders filing for TJX COMPANIES INC /DE/ (TJX)

Ricciuti John, SEVP - Group President
PINTOFF CRAIG ADAM, Director
Nemerov Jackwyn, Director
BERKERY ROSEMARY T, Director
LANE AMY B, Director
Alvarez Jose B, Director

How to read Form 4 transaction codes